{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T18:08:52Z","timestamp":1764958132765,"version":"3.46.0"},"reference-count":6,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"DOI":"10.1001\/jama.282.4.324","type":"journal-article","created":{"date-parts":[[2003,3,18]],"date-time":"2003-03-18T06:14:54Z","timestamp":1047968094000},"page":"324","source":"Crossref","is-referenced-by-count":7,"title":["Alendronate and Fracture Prevention"],"prefix":"10.1001","volume":"282","author":[{"given":"Steven R.","family":"Cummings","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"Black","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Barrett-Connor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert B.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[1999,7,28]]},"reference":[{"key":"REF-JLT0728-2-1-1","doi-asserted-by":"crossref","unstructured":"RPHeaneyBone mass, bone fragility, and the decision to treat.JAMA.1998;280:2119-2120.","DOI":"10.1001\/jama.280.24.2119"},{"key":"REF-JLT0728-2-1-2","doi-asserted-by":"crossref","unstructured":"SRCummingsDMBlackDEThompsonfor the Fracture Intervention Trial Research GroupEffect of alendronate on risk of fracture in women with low bone density\nbut without vertebral fractures: results from the Fracture Intervention Trial.JAMA.1998;280:2077-2082.","DOI":"10.1001\/jama.280.24.2077"},{"key":"REF-JLT0728-2-1-3","doi-asserted-by":"crossref","unstructured":"SHulleyDGradyTBushRandomized trial of estrogen plus progestin for secondary prevention\nof coronary heart disease in postmenopausal women.JAMA.1998;280:605-613.","DOI":"10.1001\/jama.280.7.605"},{"key":"REF-JLT0728-2-1-4","doi-asserted-by":"crossref","unstructured":"BFisherJPConstantinoLWickernamTamoxifen for the prevention of breast cancer: Report of the National\nSurgical Adjuvant Breast and Bowel Project p-1 study.J Natl Cancer Inst.1998;90:1371-1388.","DOI":"10.1093\/jnci\/90.18.1371"},{"key":"REF-JLT0728-2-1-5","unstructured":"National Osteoporosis FoundationPhysicians' Guide to Prevention and Treatment of\nOsteoporosis.Washington, DC: National Osteoporosis Foundation; 1998."},{"key":"REF-JLT0728-2-1-6","doi-asserted-by":"crossref","unstructured":"DMBlackSRCummingsDBKarpfRandomized trial of effect of alendronate on risk of fracture in women\nwith existing vertebral fractures.Lancet.1996;348:1535-1541.","DOI":"10.1016\/S0140-6736(96)07088-2"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/1030250\/jlt0728.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T18:05:08Z","timestamp":1764957908000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/1030250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,7,28]]},"references-count":6,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1999,7,28]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.282.4.324","relation":{},"ISSN":["0098-7484"],"issn-type":[{"type":"print","value":"0098-7484"}],"subject":[],"published":{"date-parts":[[1999,7,28]]}}}